Spain· ES:02223001IP1
EVRA 203 MICROGRAMOS/24 hORAS + 33,9 MICROGRAMOS/24 HORAS PARCHE TRANSDERMICO
A medicinal product containing norelgestromina + etinilestradiol, registered in Spain by Janssen-Cilag International N.V.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- norelgestromina + etinilestradiol
- Manufacturer
- Janssen-Cilag International N.V
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Norelgestromina + etinilestradiol in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesGwyn LoViatris Specialty LLC
- CzechiaEVRAGedeon Richter Plc., Budapešť
- United KingdomEvra transdermal patchesWaymade Healthcare Plc
- IrelandEvraGedeon Richter Plc
- SwitzerlandEvra, transdermales PatchGedeon Richter (Schweiz) AG
- FinlandEvraOrifarm Oy
- CanadaEVRASEARCHLIGHT PHARMA INC
- IcelandEvraGedeon Richter Plc.*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Evra
- Liechtenstein · Evra
- Norway · Evra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c1938835-6e36-4633-a385-d1ba9e938906 GET /v1/drugs/c1938835-6e36-4633-a385-d1ba9e938906?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1467895561000}",
"nregistro": "02223001IP1",
"substance": "norelgestromina + etinilestradiol"
}See everything about norelgestromina + etinilestradiol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.